tiprankstipranks
Trending News
More News >
Pelthos Therapeutics (PTHS)
:PTHS
US Market
Advertisement

Pelthos Therapeutics (PTHS) Technical Analysis

Compare
58 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
3Neutral
10Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Pelthos Therapeutics’s (PTHS) Moving Averages Convergence Divergence (MACD) indicator is -0.62, suggesting Pelthos Therapeutics is a Buy.
Pelthos Therapeutics’s (PTHS) 20-Day exponential moving average is 28.29, while Pelthos Therapeutics’s (PTHS) share price is $25, making it a Sell.
Pelthos Therapeutics’s (PTHS) 50-Day exponential moving average is 26.48, while Pelthos Therapeutics’s (PTHS) share price is $25, making it a Sell.

Pelthos Therapeutics (PTHS) Pivot Points

Oct 11, 2025, 06:04 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
21.71
23.13
24.06
25.48
26.42
27.84
28.77
Fibonacci
23.13
24.03
24.58
25.48
26.38
26.94
27.84
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pelthos Therapeutics (PTHS) Moving Averages

Oct 11, 2025, 06:04 AM
Period
Simple
Exponential
MA5
26.29Sell
25.68Sell
MA10
27.11Sell
27.19Sell
MA20
30.20Sell
28.29Sell
MA50
26.30Sell
26.48Sell
MA100
20.83Buy
22.80Buy
MA200
17.90Buy
18.41Buy
Pelthos Therapeutics’s (PTHS) 10-Day exponential moving average is 27.19, while Pelthos Therapeutics’s (PTHS) share price is $25, making it a Sell.
Pelthos Therapeutics’s (PTHS) 100-Day exponential moving average is 22.80, while Pelthos Therapeutics’s (PTHS) share price is $25, making it a Buy.
Pelthos Therapeutics’s (PTHS) stock price is $25 and Pelthos Therapeutics’s (PTHS) 50-day simple moving average is 26.30, creating a Sell signal.
Pelthos Therapeutics’s (PTHS) stock price is $25 and Pelthos Therapeutics’s (PTHS) 100-day simple moving average is 20.83, creating a Buy signal.
Pelthos Therapeutics’s (PTHS) stock price is $25 and Pelthos Therapeutics’s (PTHS) 200-day simple moving average is 17.90, creating a Buy signal.

Pelthos Therapeutics (PTHS) Technical Indicators

Oct 11, 2025, 06:04 AM
Name
Value
Implied Action
RSI (14)
33.87
Neutral
STOCH (9,6)
6.64
Buy
STOCHRSI (14)
6.64
Buy
MACD (12,26)
-0.62
Buy
ADX (14)
36.01
Neutral
Williams %R
-100.00
Buy
CCI (14)
-139.79
Buy
ATR (14)
2.11
-
Ultimate Oscillator
52.50
Neutral
ROC
-29.86
Sell
Pelthos Therapeutics’s (PTHS) Relative Strength Index (RSI) is 33.87, creating a Neutral signal.
Pelthos Therapeutics’s (PTHS) Trend Strength Indicator (ADX) is 36.01, creating a Neutral signal.
Pelthos Therapeutics’s (PTHS) Commodity Channel Index (CCI) is -139.79, creating a Buy signal.
Pelthos Therapeutics’s (PTHS) Price Rate of Change (ROC) is -29.86, creating a Sell signal.

FAQ

Is PTHS a Buy, Hold, or Sell?
Based on PTHS’s technical indicators, PTHS is a Hold.
    What is PTHS’s RSI (14)?
    PTHS’s RSI (14) is 33.87, which suggests PTHS is a Neutral.
      What is PTHS’s MACD?
      PTHS’s MACD is -0.62, which suggests PTHS is a Buy.
        What is PTHS’s 5-day moving average?
        PTHS’s 5-day moving average is 26.29, which suggests PTHS is a Sell.
          What is PTHS’s 20-day moving average?
          PTHS 20-day moving average is 30.20, which suggests PTHS is a Sell.
            What is PTHS’s 50-day moving average?
            PTHS’s 50-day moving average is 26.30, which suggests PTHS is a Sell.
              What is PTHS’s 200-day moving average?
              PTHS’s 200-day moving average is 17.90, which suggests PTHS is a Buy.
                What is PTHS’s Williams % R (14)?
                PTHS’s Williams % R (14) is -100.00, which suggests PTHS is a Buy.
                  What is PTHS’s CCI (14)?
                  PTHS’s CCI (14) is -139.79, which suggests PTHS is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis